A detailed history of Signaturefd, LLC transactions in Theravance Biopharma, Inc. stock. As of the latest transaction made, Signaturefd, LLC holds 85 shares of TBPH stock, worth $838. This represents 0.0% of its overall portfolio holdings.

Number of Shares
85
Previous 317 73.19%
Holding current value
$838
Previous $2,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

SELL
$7.66 - $10.25 $1,777 - $2,378
-232 Reduced 73.19%
85 $0
Q2 2024

Jul 29, 2024

SELL
$8.29 - $9.92 $2,230 - $2,668
-269 Reduced 45.9%
317 $2,000
Q1 2024

May 03, 2024

SELL
$8.22 - $11.59 $1,002 - $1,413
-122 Reduced 17.23%
586 $5,000
Q4 2023

Jan 31, 2024

BUY
$8.58 - $11.4 $4,753 - $6,315
554 Added 359.74%
708 $7,000
Q3 2023

Nov 03, 2023

SELL
$8.38 - $10.44 $108 - $135
-13 Reduced 7.78%
154 $1,000
Q2 2023

Aug 01, 2023

SELL
$10.16 - $11.92 $101 - $119
-10 Reduced 5.65%
167 $1,000
Q1 2023

Apr 28, 2023

SELL
$9.87 - $11.44 $3,395 - $3,935
-344 Reduced 66.03%
177 $1,000
Q4 2022

Jan 27, 2023

BUY
$9.65 - $11.34 $685 - $805
71 Added 15.78%
521 $5,000
Q3 2022

Nov 08, 2022

BUY
$8.39 - $10.22 $75 - $91
9 Added 2.04%
450 $5,000
Q2 2022

Aug 10, 2022

SELL
$8.41 - $10.34 $445 - $548
-53 Reduced 10.73%
441 $4,000
Q1 2022

May 02, 2022

BUY
$8.33 - $12.96 $1,541 - $2,397
185 Added 59.87%
494 $5,000
Q4 2021

Jan 25, 2022

BUY
$7.42 - $11.05 $1,142 - $1,701
154 Added 99.35%
309 $3,000
Q3 2021

Oct 28, 2021

SELL
$6.77 - $14.41 $33 - $72
-5 Reduced 3.13%
155 $1,000
Q2 2021

Jul 26, 2021

SELL
$14.52 - $22.46 $2,874 - $4,447
-198 Reduced 55.31%
160 $2,000
Q1 2021

Apr 30, 2021

BUY
$16.57 - $21.08 $4,573 - $5,818
276 Added 336.59%
358 $7,000
Q3 2020

Nov 03, 2020

BUY
$14.79 - $22.49 $340 - $517
23 Added 38.98%
82 $1,000
Q2 2020

Jul 30, 2020

BUY
$20.64 - $30.69 $1,217 - $1,810
59 New
59 $1,000
Q3 2018

Nov 15, 2018

SELL
$22.83 - $32.67 $4,566 - $6,534
-200 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$22.06 - $25.52 $4,412 - $5,104
200 New
200 $5,000

Others Institutions Holding TBPH

About Theravance Biopharma, Inc.


  • Ticker TBPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 66,782,400
  • Market Cap $658M
  • Description
  • Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...
More about TBPH
Track This Portfolio

Track Signaturefd, LLC Portfolio

Follow Signaturefd, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.